249 related articles for article (PubMed ID: 28345518)
1. Oropharyngeal squamous cell carcinoma and HPV. Systematic review on overall management.
De Santis S; Spinosi MC; Cambi J; Bengala C; Boccuzzi S
J Stomatol Oral Maxillofac Surg; 2017 Apr; 118(2):103-108. PubMed ID: 28345518
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
3. Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.
Bonilla-Velez J; Mroz EA; Hammon RJ; Rocco JW
Otolaryngol Clin North Am; 2013 Aug; 46(4):521-43. PubMed ID: 23910468
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
6. HPV in oropharyngeal cancer: the basics to know in clinical practice.
Elrefaey S; Massaro MA; Chiocca S; Chiesa F; Ansarin M
Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):299-309. PubMed ID: 25709145
[TBL] [Abstract][Full Text] [Related]
7. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
Lim MY; Dahlstrom KR; Sturgis EM; Li G
Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
[TBL] [Abstract][Full Text] [Related]
9. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
[TBL] [Abstract][Full Text] [Related]
10. The role of human papillomavirus infection in head and neck cancers.
Syrjänen S
Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
12. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
13. The impact of HPV testing for oropharyngeal cancers: Why the addendum matters.
Beadle BM
Cancer Cytopathol; 2017 May; 125(5):301-302. PubMed ID: 28241100
[No Abstract] [Full Text] [Related]
14. Human papillomavirus: changing paradigms in oropharyngeal cancer.
Adelstein DJ; Rodriguez CP
Curr Oncol Rep; 2010 Mar; 12(2):115-20. PubMed ID: 20425596
[TBL] [Abstract][Full Text] [Related]
15. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
17. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
19. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
[TBL] [Abstract][Full Text] [Related]
20. [HPV infection in head and neck squamous cell carcinoma (HNSCC). Highlights from ASCO 2010].
Ihloff AS; Knecht R; Tribius S
HNO; 2010 Dec; 58(12):1163-7. PubMed ID: 20963389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]